- Presentations
- 2
- Markets
- 1
Fasenra is a brand of Benralizumab marketed by AstraZeneca Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Benralizumab
- Brand owner
- AstraZeneca Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 10 mg/0.5 mL injection, 30 mg/1 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Fasenra 10 mg/0.5 mL injectionSubcutaneous Cold chain | AstraZeneca Pharmaceuticals | US FDA | Available on request |
| Fasenra 30 mg/1 mL injectionSubcutaneous Cold chain | AstraZeneca Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Fasenra
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.